Skip to search formSkip to main contentSkip to account menu

25 ML Daunorubicin Liposomal 2 MG/ML Injection [DaunoXome]

Known as: 25 ML DaunoXome 2 MG/ML Injection, DaunoXome 50 MG in 25 ML Injection, DaunoXome 50 MG per 25 ML Injection 
National Institutes of Health

Related topics

Related topics

3 relations
DaunoXomeInjection

Broader (1)

Daunorubicin Liposomal Injection [DaunoXome]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Traitement de la maladie de Kaposi associée au sida par la daunorubicine liposomale (Daunoxome®). Étude rétrospective multicentrique de 94 patients traités entre septembre 1996 et 1997
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)